Literature DB >> 17447002

Platelet phospholipase A2 activity in patients with Alzheimer's disease, vascular dementia and ischemic stroke.

E Krzystanek1, M Krzystanek, G Opala, H I Trzeciak, J Siuda, A Małecki.   

Abstract

Phospholipase A(2) (E.C. 3.1.1.4, PLA(2)) plays an essential role in metabolism of membrane phospholipids, it is related to inflammatory reactions, secretion of amyloid precursor protein and activation of NMDA receptor after ischemia. In the present study we investigated PLA(2) activity in platelets from 37 Alzheimer's disease (AD) patients, 32 vascular dementia (VaD) patients and 32 individuals with ischemic stroke as compared to 27 healthy elderly controls. PLA(2) activity was determined using radiometric assay. Mean platelet PLA(2) activity was increased in individuals with Alzheimer's disease (p < 0.001). In VaD group the enzyme activity was between the values in AD and controls, these differences being significant from both groups. In the group of patients with ischemic stroke mean PLA(2) activity was higher either 48 h after the stroke or 7 days later (in both cases p < 0.001). The results may be particularly interesting in light of the fact, that inhibitors of PLA(2) activity are known.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17447002     DOI: 10.1007/s00702-007-0669-9

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  51 in total

1.  Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer's disease brain.

Authors:  D T Stephenson; C A Lemere; D J Selkoe; J A Clemens
Journal:  Neurobiol Dis       Date:  1996-02       Impact factor: 5.996

2.  Assay of platelet ATP and ADP by the luciferase method: some theoretical and practical aspects.

Authors:  J L David; F Herion
Journal:  Adv Exp Med Biol       Date:  1972       Impact factor: 2.622

3.  A beta vasoactivity: an inflammatory reaction.

Authors:  D Paris; T Town; T Parker; J Humphrey; M Mullan
Journal:  Ann N Y Acad Sci       Date:  2000-04       Impact factor: 5.691

4.  Guanine nucleotides and fluoride enhance carbachol-mediated arachidonic acid release from phosphatidylinositol. Evidence for involvement of GTP-binding protein in phospholipase A2 activation.

Authors:  J Strosznajder; R P Strosznajder
Journal:  J Lipid Mediat       Date:  1989 Jul-Aug

5.  Increased platelet phospholipase A2 activity in schizophrenia.

Authors:  W F Gattaz; A Schmitt; A Maras
Journal:  Schizophr Res       Date:  1995-07       Impact factor: 4.939

6.  Citicoline decreases phospholipase A2 stimulation and hydroxyl radical generation in transient cerebral ischemia.

Authors:  Rao Muralikrishna Adibhatla; James F Hatcher
Journal:  J Neurosci Res       Date:  2003-08-01       Impact factor: 4.164

Review 7.  Citicoline mechanisms and clinical efficacy in cerebral ischemia.

Authors:  Rao Muralikrishna Adibhatla; J F Hatcher
Journal:  J Neurosci Res       Date:  2002-10-15       Impact factor: 4.164

8.  Synthesis of phosphatidylethanol--a potential marker for adult males at risk for alcoholism.

Authors:  G C Mueller; M F Fleming; M A LeMahieu; G S Lybrand; K J Barry
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

9.  Platelet secretory phospholipase A2 fails to induce rabbit platelet activation and to release arachidonic acid in contrast with venom phospholipases A2.

Authors:  C Mounier; B B Vargaftig; P A Franken; H M Verheij; C Bon; L Touqui
Journal:  Biochim Biophys Acta       Date:  1994-08-25

10.  Decreased phospholipase A2 activity in the brain and in platelets of patients with Alzheimer's disease.

Authors:  W F Gattaz; N J Cairns; R Levy; H Förstl; D F Braus; A Maras
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

View more
  7 in total

1.  Comparative Use of Contralateral and Sham-Operated Controls Reveals Traces of a Bilateral Genetic Response in the Rat Brain after Focal Stroke.

Authors:  Ivan B Filippenkov; Julia A Remizova; Alina E Denisova; Vasily V Stavchansky; Ksenia D Golovina; Leonid V Gubsky; Svetlana A Limborska; Lyudmila V Dergunova
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

2.  Low platelet iPLA₂ activity predicts conversion from mild cognitive impairment to Alzheimer's disease: a 4-year follow-up study.

Authors:  Wagner F Gattaz; Leda L Talib; Evelin L Schaeffer; Breno S Diniz; Orestes V Forlenza
Journal:  J Neural Transm (Vienna)       Date:  2013-09-15       Impact factor: 3.575

3.  Impacts of membrane biophysics in Alzheimer's disease: from amyloid precursor protein processing to aβ Peptide-induced membrane changes.

Authors:  Sholpan Askarova; Xiaoguang Yang; James C-M Lee
Journal:  Int J Alzheimers Dis       Date:  2011-03-17

Review 4.  Biomarkers for early diagnosis of Alzheimer disease: 'ALZheimer ASsociated gene'--a new blood biomarker?

Authors:  Kurt A Jellinger; Bernd Janetzky; Johannes Attems; Elisabeth Kienzl
Journal:  J Cell Mol Med       Date:  2008-03-19       Impact factor: 5.310

5.  Alzheimer disease and platelets: how's that relevant.

Authors:  Silvia Catricala; Mauro Torti; Giovanni Ricevuti
Journal:  Immun Ageing       Date:  2012-09-17       Impact factor: 6.400

Review 6.  Platelets, a reliable source for peripheral Alzheimer's disease biomarkers?

Authors:  Michael Veitinger; Balazs Varga; Sheila B Guterres; Maria Zellner
Journal:  Acta Neuropathol Commun       Date:  2014-06-16       Impact factor: 7.801

7.  Cognitive Stimulation Modulates Platelet Total Phospholipases A2 Activity in Subjects with Mild Cognitive Impairment.

Authors:  Marta Balietti; Cinzia Giuli; Patrizia Fattoretti; Paolo Fabbietti; Demetrio Postacchini; Fiorenzo Conti
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.